Drug Information

Drug General Information
Drug ID
D0F8AR
Former ID
DIB019355
Drug Name
compound 22
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530505], [541687]
Structure
Download
2D MOL
Formula
C37H38N3O7P
InChI
InChI=1S/C37H38N3O7P/c41-35(39-33(36(42)43)22-29-23-38-32-19-11-10-18-31(29)32)30(20-26-12-4-1-5-13-26)25-48(45,46)34(21-27-14-6-2-7-15-27)40-37(44)47-24-28-16-8-3-9-17-28/h1-19,23,30,33-34,38H,20-22,24-25H2,(H,39,41)(H,40,44)(H,42,43)(H,45,46)/t30?,33-,34+/m0/s1
InChIKey
WWTBZEKOSBFBEM-SPWPXUSOSA-N
PubChem Compound ID
45485268
PubChem Substance ID
103703202, 104157687, 178103176
Target and Pathway
Target(s) Endothelin-converting enzyme 1 Target Info Inhibitor [530505]
PANTHER Pathway Endothelin signaling pathway
WikiPathways SIDS Susceptibility Pathways
Corticotropin-releasing hormone
Endothelin Pathways
References
Ref 530505J Med Chem. 2010 Jan 14;53(1):208-20.Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.
Ref 541687(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6562).
Ref 530505J Med Chem. 2010 Jan 14;53(1):208-20.Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.